1. Home
  2. NNVC vs ZLAB Comparison

NNVC vs ZLAB Comparison

Compare NNVC & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNVC
  • ZLAB
  • Stock Information
  • Founded
  • NNVC 2005
  • ZLAB 2013
  • Country
  • NNVC United States
  • ZLAB China
  • Employees
  • NNVC N/A
  • ZLAB N/A
  • Industry
  • NNVC Biotechnology: Pharmaceutical Preparations
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNVC Health Care
  • ZLAB Health Care
  • Exchange
  • NNVC Nasdaq
  • ZLAB Nasdaq
  • Market Cap
  • NNVC N/A
  • ZLAB 3.5B
  • IPO Year
  • NNVC N/A
  • ZLAB 2017
  • Fundamental
  • Price
  • NNVC $1.35
  • ZLAB $29.24
  • Analyst Decision
  • NNVC Strong Buy
  • ZLAB Buy
  • Analyst Count
  • NNVC 1
  • ZLAB 4
  • Target Price
  • NNVC $6.50
  • ZLAB $47.37
  • AVG Volume (30 Days)
  • NNVC 108.5K
  • ZLAB 1.2M
  • Earning Date
  • NNVC 05-19-2025
  • ZLAB 05-08-2025
  • Dividend Yield
  • NNVC N/A
  • ZLAB N/A
  • EPS Growth
  • NNVC N/A
  • ZLAB N/A
  • EPS
  • NNVC N/A
  • ZLAB N/A
  • Revenue
  • NNVC N/A
  • ZLAB $418,326,000.00
  • Revenue This Year
  • NNVC N/A
  • ZLAB $44.43
  • Revenue Next Year
  • NNVC N/A
  • ZLAB $48.68
  • P/E Ratio
  • NNVC N/A
  • ZLAB N/A
  • Revenue Growth
  • NNVC N/A
  • ZLAB 43.72
  • 52 Week Low
  • NNVC $0.94
  • ZLAB $15.65
  • 52 Week High
  • NNVC $3.59
  • ZLAB $39.77
  • Technical
  • Relative Strength Index (RSI)
  • NNVC 59.88
  • ZLAB 42.71
  • Support Level
  • NNVC $1.20
  • ZLAB $27.61
  • Resistance Level
  • NNVC $1.45
  • ZLAB $32.02
  • Average True Range (ATR)
  • NNVC 0.08
  • ZLAB 1.23
  • MACD
  • NNVC 0.00
  • ZLAB -0.18
  • Stochastic Oscillator
  • NNVC 86.08
  • ZLAB 23.41

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: